Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

PaperCitations, authors & open-access status

OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,379 citations, 2012 year and bronze oa status.

1,379
Citations
2012
Year
bronze
OA Status

Related on ScholarIQ

Carol Aghajanian
Author
Journal of Clinical Oncology
Journal
Ovarian cancer diagnosis and treatment
Topic
Ovarian cancer diagnosis and treatment
Topic
Intraperitoneal and Appendiceal Malignancies
Topic
PARP inhibition in cancer therapy
Topic
470M+ articles · free account